Rapid targeted analysis of the genome: Rapid genomic sequencing in critically ill infants

rTAG-I produced a high rate of reportable findings with a rapid turnaround time. Our ability to predict infants who would benefit most was imperfect, reinforcing that broad access to genome-based testing is still required.